Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
12.43
+0.54 (4.54%)
May 8, 2025, 11:09 AM - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $677.89 million as of May 8, 2025.
Market Cap
677.89M
Enterprise Value
159.46M
1-Year Change
n/a
Ranking
Category
Stock Price
12.43
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $677.89M, a decrease of -27.24%. That is a compound annual growth rate of -38.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 648.44M | -31.59% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.21B |
| Johnson & Johnson | 373.35B |
| UnitedHealth Group | 369.55B |
| AbbVie | 346.38B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.02B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |